8-K

InspireMD, Inc. (NSPR)

8-K 2025-06-03 For: 2025-06-03
View Original
Added on April 06, 2026

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

Washington,

D.C. 20549



FORM

8-K



CURRENT

REPORT

Pursuant

to Section 13 OR 15(d) of The Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): June 3, 2025



InspireMD,Inc.

(Exactname of registrant as specified in its charter)

Delaware 001-35731 26-2123838
(State or other jurisdiction of incorporation) (Commission<br><br> <br>File Number) (IRS Employer Identification No.)
6303 Waterford District Drive, Suite 215<br><br> <br>Miami, Florida 33126 6744832
--- ---
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (888) 776-6804

(Formername or former address, if changed since last report.)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written<br> communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting<br>material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement<br>communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement<br>communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities

registered pursuant to Section 12(b) of the Act:


Title of each class Trading Symbol(s) Name of each exchange on which registered
Common<br> Stock, $0.0001 par value per share NSPR The<br> Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item5.07. Submission of Matters to a Vote of Security Holders.

On June 3, 2025, InspireMD, Inc. (the “Company”) held its 2025 annual meeting of stockholders (the “Annual Meeting”). As of April 15, 2025, the record date for the Annual Meeting, there were 30,635,356 shares of common stock issued and outstanding and entitled to vote on the proposals presented at the Annual Meeting, of which 20,478,807, or 66.84%, were present in person or represented by proxy, which constituted a quorum. The holders of shares of the Company common stock are entitled to one vote for each share held. Set forth below are the final voting results for each of the proposals submitted to a vote of the Company’s stockholders at the Annual Meeting.

ProposalNo. 1 – Election of Directors.

The stockholders re-elected Michael Berman and Scott R. Ward to serve on the board of directors of the Company, as Class 2 directors, for a term of three years or until their respective successor is elected and qualified. The votes were as follows:

Director Name For Withheld Broker Non-Votes
Michael<br> Berman 12,429,779 248,915 7,800,113
Scott<br> R. Ward 12,447,235 231,459 7,800,113

ProposalNo. 2 – Ratification of Auditors.

The stockholders ratified the appointment of Kesselman & Kesselman, a member of PricewaterhouseCoopers International Limited, as the Company’s independent registered public accounting firm for the 2025 fiscal year. The votes were as follows:

For Against Abstain
20,308,180 164,980 5,647

Item9.01 Financial Statements and Exhibits.

(d) Exhibits.

ExhibitNumber Description
104 Cover<br> Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

INSPIREMD, INC.
Date: June 3, 2025 By: /s/ Craig Shore
Name: Craig Shore
Title: Chief Financial Officer